| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 04/19/2011 | US7928119 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 04/19/2011 | US7928075 Binding agents which inhibit myostatin |
| 04/19/2011 | US7927821 Methods of screening for compounds which bind G protein-coupled receptors |
| 04/19/2011 | US7927622 Methods of transnasal transport/immunization with highly adaptable carriers |
| 04/19/2011 | CA2370289C Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
| 04/14/2011 | WO2011041937A1 Use of hydroxytyrosol for improving muscle differentiation |
| 04/14/2011 | WO2010123243A3 Composition containing a testis extract for treating or preventing diseases |
| 04/14/2011 | US20110086836 Substituted Phenylpiperidine Derivatives As Melanocortin-4 Receptor Modulators |
| 04/14/2011 | US20110086050 Glycoprotein compositions |
| 04/14/2011 | US20110086042 Centrosomal Proteins, Nucleic Acids and Method of Use Thereof |
| 04/14/2011 | CA2776950A1 Methods for preventing or treating sarcopenia and muscle atrophy in animals |
| 04/13/2011 | EP2308963A2 System for processing lipoaspirate cells |
| 04/13/2011 | EP2308876A1 Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists |
| 04/13/2011 | EP2308861A1 Macrocyclic compounds useful as pharmaceuticals |
| 04/13/2011 | EP2308855A1 2,4-Diaminopyrimidine derivatives |
| 04/13/2011 | EP2308846A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308845A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308844A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308833A2 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2011 | EP2308493A1 Ameliorating or therapeutic agent for dyslipidemia |
| 04/13/2011 | EP2308482A1 Novel use of peptide compounds for treating muscle pain |
| 04/13/2011 | EP2307044A1 Orally administrable dosage forms comprising angiogenin and uses thereof |
| 04/13/2011 | EP2307007A1 Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation |
| 04/13/2011 | EP1840208B1 Method of inducing differentiation of skeletal muscle cell |
| 04/13/2011 | EP1542978B1 Novel bio-active molecules |
| 04/13/2011 | EP1539763B1 Azaindole kinase inhibitors |
| 04/13/2011 | CN1882547B 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 04/13/2011 | CN102014921A Composition for modulating stem cell growth with prostaglandins |
| 04/13/2011 | CN102008674A Plaster for treating herniated disk, hyperosteogeny and rheumatoid diseases and preparation method thereof |
| 04/13/2011 | CN102008551A Medicinal composition for treating pains of necks, shoulders and arms and preparation method and application thereof |
| 04/13/2011 | CN102008474A Application of nitidine chloride to preparation of medicament for resisting autoimmunity disease and graft versus host disease |
| 04/13/2011 | CN102008468A Application of Incarvillea delavay alkali in preparing drug for resisting autoimmune diseases and graft rejection diseases |
| 04/13/2011 | CN102008439A Curcumin coated liposome preparation and preparation method thereof |
| 04/12/2011 | US7923246 Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor |
| 04/07/2011 | WO2011040823A1 Synthetic myostatin peptide antagonists |
| 04/07/2011 | WO2011038471A1 Pharmaceutical composition and use thereof |
| 04/07/2011 | US20110082178 Methods of treating autoimmune and inflammatory diseases and disorders |
| 04/07/2011 | US20110081320 Treatment/Cure of Autoimmune Disease |
| 04/07/2011 | CA2776529A1 Synthetic myostatin peptide antagonists |
| 04/06/2011 | EP2305795A1 Method of collecting placental stem cells |
| 04/06/2011 | EP2305305A1 Agent for induction/maintenance of remission |
| 04/06/2011 | EP2305276A2 Processed lipoaspirate cells for use in therapy |
| 04/06/2011 | EP2305253A1 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 04/06/2011 | EP2305252A1 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 04/06/2011 | EP2305213A2 The treatment of small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 04/06/2011 | EP2303336A2 Sulfonylurea receptor and means for treating ischaemia |
| 04/06/2011 | EP2303311A1 Use of angiogenin or angiogenin agonists for treating diseases and disorders |
| 04/06/2011 | EP2303297A1 Water-soluble extracts of artemisia dracunculus (tarragon) for improvement of glucose metabolism |
| 04/06/2011 | EP2303278A1 Composition for modulating stem cell growth with prostaglandins |
| 04/06/2011 | EP2303262A1 Dpp-iv inhibitors for use in the treatment of nafld |
| 04/06/2011 | EP2303040A1 Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon |
| 04/06/2011 | CN1658893B G-type peptides to ameliorate atherosclerosis |
| 04/06/2011 | CN1376146B Solid-state form of celecoxil having enhanced bioavailability |
| 04/06/2011 | CN102002050A Bisbenzylisoquinoline derivative and preparation and application thereof |
| 04/06/2011 | CN102000275A Medicinal composition for treating children with tic disorders and preparation method thereof |
| 04/06/2011 | CN102000254A Traditional Chinese medicine preparation for treating phrenospasm |
| 04/05/2011 | US7919513 Inhibitors of p38 |
| 04/05/2011 | CA2494695C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 03/31/2011 | WO2010151042A3 Use of schizandra chinensis baillon and chaenomeles sinensis extracts for alleviating muscle fatigue and muscle pain or for enhancing exercise capability |
| 03/31/2011 | US20110078804 Angiogenin and Amyotrophic Lateral Sclerosis |
| 03/31/2011 | US20110077300 Metabolic Benefits to Butyrate as a Chronic Diet Supplement |
| 03/31/2011 | US20110077221 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 03/31/2011 | US20110077208 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 03/31/2011 | US20110077194 Method for Treating or Preventing a Functional Vitamin B12 Deficiency in an Individual and to Medical Compositions for Use in Said Method |
| 03/31/2011 | US20110076344 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 03/31/2011 | US20110076236 Compositions and methods of treatment using modulators of motoneuron diseases |
| 03/30/2011 | EP2301971A1 Antibodies that bind both BCMA and TACI |
| 03/30/2011 | EP2301970A1 Human antibodies that bind human IL-12 and methods for producing |
| 03/30/2011 | EP2301563A2 HSP20 peptides |
| 03/30/2011 | EP2301534A1 Amino-methyl substituted tetracycline compounds |
| 03/30/2011 | EP2301343A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 03/30/2011 | EP1317485B1 Myostatin antagonists and uses thereof |
| 03/30/2011 | CN101998854A Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cycklopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 03/30/2011 | CN101993470A Process for preparing high-purity rocuronium |
| 03/30/2011 | CN101993281A Culture medium of ganoderma capense (Lloyd) Teng fungus for preparing Baozhi glycopeptide injection |
| 03/30/2011 | CN101991859A Beta-cyclodextrin inclusion compound of huperzine A, and preparation method and preparation thereof |
| 03/30/2011 | CN101991735A External-application ointment |
| 03/30/2011 | CN101991566A Application of lariciresinol to preparing medicament for resisting autoimmune disease and graft rejection disease |
| 03/30/2011 | CN101712649B Lotus leaf extract, monomer component and application thereof |
| 03/29/2011 | US7915280 Compounds and their uses |
| 03/29/2011 | US7915265 Combinations for the treatment of immunoinflammatory disorders |
| 03/29/2011 | US7915226 Methods of suppressing microglial activation |
| 03/29/2011 | CA2462211C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 03/29/2011 | CA2420562C Creatine ester pronutrient compounds and formulations |
| 03/29/2011 | CA2383779C N-(indolecarbonyl)piperazine derivatives |
| 03/24/2011 | WO2011034920A1 Compositions and methods for treating seizure disorders |
| 03/24/2011 | WO2011034912A1 Compositions and methods for treating spasticity |
| 03/24/2011 | WO2011034532A1 Stilbene-based compositions and methods of use therefor |
| 03/24/2011 | WO2011034078A1 Glycine compound |
| 03/24/2011 | WO2011033884A1 Prophylactic agent for muscular contracture |
| 03/24/2011 | WO2010138670A3 Thiocolchicine derivatives, method of making and methods of use thereof |
| 03/24/2011 | WO2010129406A3 Methods of promoting muscle growth |
| 03/24/2011 | WO2010108001A3 Agents and methods for tissue repair and regeneration |
| 03/24/2011 | US20110071098 Flurbiprofen and muscle relaxant gel combinations thereof |
| 03/24/2011 | US20110070233 Actriib antagonists and dosing and uses thereof |
| 03/24/2011 | CA2774359A1 Compositions and methods for treating seizure disorders |
| 03/24/2011 | CA2774355A1 Compositions and methods for treating spasticity |
| 03/24/2011 | CA2772689A1 Glycine compound |
| 03/23/2011 | EP2298815A1 B-cell reduction using CD37-specific and CD20-specific binding molecules |
| 03/23/2011 | EP2298803A2 Human G-protein coupled receptor and ligands thereof |